Beyond conventional antibiotics - New directions for combination products to combat biofilm

被引:56
作者
Bayramov, Danir Fanisovich [1 ]
Neff, Jennifer Ann [1 ]
机构
[1] Allvivo Vasc Inc, 20914 Bake Pkwy,Suite 100, Lake Forest, CA 92630 USA
基金
美国国家卫生研究院;
关键词
Antimicrobial; Antimicrobial peptides; Antibiotic resistance; Compartment model; Local drug delivery; Medical device coatings; CATIONIC ANTIMICROBIAL PEPTIDES; CENTRAL VENOUS CATHETERS; HOST-DEFENSE PEPTIDES; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; IN-VITRO; STAPHYLOCOCCUS-AUREUS; MICROBIAL BIOFILMS; RESISTANCE MECHANISMS; GENTAMICIN-RELEASE;
D O I
10.1016/j.addr.2016.07.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medical device related infections are a significant and growing source of morbidity and mortality. Biofilm formation is a common feature of medical device infections that is not effectively prevented or treated by systemic antibiotics. Antimicrobialmedical device combination products provide a pathway for local delivery of antimicrobial therapeutics with the ability to achieve high local concentrations while minimizing systemic side effects. In this review, we present considerations for the design of local antimicrobial delivery systems, which can be facilitated by modeling local pharmacokinetics in the context of the target device application. In addition to the need for local delivery, a critical barrier to progress in the field is the need to incorporate agents effective against bio-film. This article aims to review key properties of antimicrobial peptides that make them well suited to meet the demands of the next generation of antimicrobial medical devices, including broad spectrum activity, rapid and biocidal mechanisms of action, and efficacy against biofilm. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 60
页数:13
相关论文
共 194 条
  • [1] Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617
  • [2] AI-2/LuxS Is Involved in Increased Biofilm Formation by Streptococcus intermedius in the Presence of Antibiotics
    Ahmed, Nibras A.
    Petersen, Fernanda C.
    Scheie, Anne A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4258 - 4263
  • [3] Excipient-drug interactions in parenteral formulations
    Akers, MJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (11) : 2283 - 2300
  • [4] Ammons Mary C B, 2010, Recent Pat Antiinfect Drug Discov, V5, P10
  • [5] Underresourced hospital infection control and prevention programs: Penny wise, pound foolish?
    Anderson, Deverick J.
    Kirkland, Kathryn B.
    Kaye, Keith S.
    Thacker, Paul A., II
    Kanafani, Zeina A.
    Auten, Grace
    Sexton, Daniel J.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (07) : 767 - 773
  • [6] [Anonymous], 2013, INT J BIOMED MAT RES
  • [7] Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects
    Arciola, Carla Renata
    Campoccia, Davide
    Ravaioli, Stefano
    Montanaro, Lucio
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2015, 5
  • [8] Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery
    Arruebo, Manuel
    Vilaboa, Nuria
    Santamaria, Jesus
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (05) : 589 - 603
  • [9] Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits
    Batoni, Giovanna
    Maisetta, Giuseppantonio
    Brancatisano, Franca Lisa
    Esin, Semih
    Campa, Mario
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (02) : 256 - 279
  • [10] Bauer L., 2008, CLIN PHARMACOKINET, P34